Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 65 (5), 1568-1576
- https://doi.org/10.1111/j.1523-1755.2004.00552.x
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Third-Generation β-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP EffluxCirculation, 2003
- Simvastatin Normalizes Autonomic Neural Control in Experimental Heart FailureCirculation, 2003
- Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2003
- Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2003
- Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysisKidney International, 2002
- Sympathetically Mediated Hypertension Caused by Chronic Inhibition of Nitric OxideHypertension, 1995
- Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?Hypertension, 1994
- Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.Hypertension, 1993
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Hemodynamics of Hypertension in Chronic End-Stage Renal DiseaseCirculation, 1972